|
|
1. MARKET OVERVIEW
|
Influencer Market Insights |
World Market Trajectories |
Novel Drug Delivery Systems (NDDS) – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
Impact of Covid-19 and a Looming Global Recession |
2020: A Year of Disruption & Transformation |
As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021 |
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022 |
An Insight into Pandemic Impact on Pharmaceuticals Industry |
COVID-19 & Other Factors Shift Focus to Different Drug Delivery Approaches |
Novel Drug Delivery Systems Gain Interest Amid the Fight Against COVID-19 |
Nanomaterial-enabled Novel Drug Delivery Systems Gain Interest in Vaccine Development |
Novel Drug Delivery System (NDDS): A Prelude |
Versatile Benefits of NDDS Drive Companies to Embrace the Drug Delivery Approach |
Patient Compliance: A Key Reason Garnering Interest in NDD |
Regulatory Process for Novel Drug Delivery Systems |
A Look into Current Areas of Research in Drug Delivery |
Market Outlook |
Nanotechnology-Enabled Drug Delivery: Primary Challenges |
Recent Market Activity |
2. FOCUS ON SELECT PLAYERS
|
3. MARKET TRENDS & DRIVERS
|
Nanotechnology Bolsters Demand for NDDS |
Prospects Remain Encouraging |
Microfluidics Mediated NDDS Set to Make Gains |
Nanocarriers Enable Targeted Drug Delivery Systems to Improve Therapeutic Outcomes |
Advanced Liposomes Enable Low Soluble Drugs to Achieve Targeted Delivery |
List of Marketed Liposome-Based Clinical Products Classified by Therapeutic Areas |
Liposomes-based Drug Delivery Systems to touch Diverse Areas of Modern Medicine |
Dendrimers as Ideal Drug Delivery Agents |
List of Commercially Available Dendrimeric Products by Application Area |
High Drug Loading Capacity of PAMAM Dendrimers Bodes Well for Targeted Drug Delivery Systems |
Oral Thin Films Enhance NDDS Domain |
Nanotechnology-Enabled Drug Delivery Opens New Horizons to Improve Cancer Treatments |
Rising Cancer Incidence Drives Focus onto Novel Drug Delivery Mechanisms |
EXHIBIT 8: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 |
EXHIBIT 10: Number of New Cancer Cases and Deaths (in Million) by Region for 2020 |
EXHIBIT 11: Global Breakdown of Total Number of Cancer Cases by Type: 2020 |
Novel Drug Delivery System Emerges as a Potential Treatment for Pediatric Brain Tumors |
Uptrend in Gene Therapy Market Augurs Well for Market Growth |
Exhibit: Global Gene Therapy Market in US$ Million: 2020, 20223 and 2024 |
Adeno-Associated Virus Vectors: A Leading Platform for Gene Therapy |
Application of Nanotechnology-based Drug Delivery Systems for CVD Treatment |
EXHIBIT 12: Global Annual Medical Cost of CVD in US$ Billion (2020-2030) |
NDD for Antimicrobial Drugs |
List of Select Nanotechnology-based Antimicrobial Drugs in Clinical Use |
Nanotechnology Opens New Avenues in Antiretroviral Therapy |
Demonstrated Activity of Select Nanotechnology-Delivered Antiretroviral Therapies |
Novel Drug Delivery System Exhibits Potential to Target HIV Reservoirs |
EXHIBIT 11: Global HIV Prevalence Seeks Need for Novel Drug Delivery Systems: Number of People Living with AIDs (in Thousands) by Region for 2020 |
Novel Drug Delivery Systems for CNS Therapeutics |
Novel Drug and a New Delivery Method for Restoring Brain Cells in People Suffering from PD |
Nanotechnology Powers Next Wave of Change for Neglected Tropical Diseases’ Treatment |
Novel Drug Delivery Systems Hold Edge over Existing Therapies for Diabetic Retinopathy |
Exciting Immunology Developments Involving Graphene-based Nanomaterials |
Nanotechnology-Based Strategies for siRNA Grows in Popularity |
Nanoemulsions Begin to Make a Mark |
Inorganic Nanocarriers Facilitate High Payload Capacity and Co-Delivery Platforms for MDR Cancer Therapy |
Solid Lipid Nanoparticles Provide Increased Physical Stability in Targeted Drug Delivery |
Recent Advancements in Polymeric Drug Delivery Systems |
Pulmonary Delivery of Nanoparticle-Based Drugs Receives Increased Interest |
Inhalable Liposome Formulations Attract Research Interest in Pulmonary Delivery |
SLNs in Pulmonary Delivery of Drugs |
Other Nanocarriers in Pulmonary Delivery |
Increasing Importance of Gold Nanoparticles in Targeted Drug Administration |
Gold Nanoparticles Open New Avenues in Combinatorial Cancer Therapy |
Consistent Rise in Healthcare Spending Worldwide to Drive Market Opportunities |
EXHIBIT 14: World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 and 2023 |
4. GLOBAL MARKET PERSPECTIVE
|
World Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030 |
World Recent Past, Current & Future Analysis for Nanoparticles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World 8-Year Perspective for Nanoparticles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030 |
World Recent Past, Current & Future Analysis for Embolization Particles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
World 8-Year Perspective for Embolization Particles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030 |
World Novel Drug Delivery Systems (NDDS) Market Analysis of Annual Sales in US$ Million for Years 2020 through 2030 |
|
UNITED STATES
|
Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E) |
USA Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
USA 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030 |
CANADA
|
Canada Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Canada 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030 |
JAPAN
|
Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E) |
Japan Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Japan 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030 |
CHINA
|
Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E) |
China Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
China 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030 |
EUROPE
|
Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E) |
Europe Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR |
Europe 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030 |
Europe Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Europe 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030 |
FRANCE
|
Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E) |
France Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
France 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030 |
GERMANY
|
Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E) |
Germany Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Germany 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030 |
ITALY
|
Italy Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Italy 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030 |
UNITED KINGDOM
|
Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E) |
UK Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
UK 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030 |
REST OF EUROPE
|
Rest of Europe Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of Europe 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030 |
ASIA-PACIFIC
|
Novel Drug Delivery Systems (NDDS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Asia-Pacific 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030 |
REST OF WORLD
|
Rest of World Recent Past, Current & Future Analysis for Novel Drug Delivery Systems (NDDS) by Segment - Nanoparticles and Embolization Particles - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR |
Rest of World 8-Year Perspective for Novel Drug Delivery Systems (NDDS) by Segment - Percentage Breakdown of Value Sales for Nanoparticles and Embolization Particles for the Years 2023 & 2030 |
|
|